| Primary |
| Prophylaxis Of Neural Tube Defect |
40.0% |
| Schizophrenia |
40.0% |
| Vulvovaginal Mycotic Infection |
20.0% |
|
| Spine Malformation |
60.0% |
| Hyponatraemia |
20.0% |
| Somnolence |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
44.7% |
| Drug Abuse |
29.5% |
| Drug Use For Unknown Indication |
5.8% |
| Depression |
5.4% |
| Hypertension |
1.8% |
| Foetal Exposure During Pregnancy |
1.7% |
| Vulvovaginal Mycotic Infection |
1.6% |
| Polycystic Ovaries |
1.4% |
| Accidental Exposure |
1.2% |
| Prophylaxis Of Neural Tube Defect |
1.2% |
| Sleep Disorder |
1.2% |
| Delirium |
1.0% |
| Anxiety Disorder |
0.5% |
| Circadian Rhythm Sleep Disorder |
0.5% |
| Factor V Leiden Mutation |
0.5% |
| Gastritis Prophylaxis |
0.5% |
| Pain |
0.5% |
| Pneumonia |
0.4% |
| Pulmonary Fibrosis |
0.4% |
| Anxiety |
0.3% |
|
| Spine Malformation |
15.1% |
| Sudden Death |
8.2% |
| Delirium |
6.8% |
| Atrial Flutter |
5.5% |
| Cardiac Arrest |
5.5% |
| Hyponatraemia |
5.5% |
| Tachycardia |
5.5% |
| Vulvovaginal Mycotic Infection |
5.5% |
| Cardiomyopathy |
4.1% |
| Dehydration |
4.1% |
| Gastroenteritis Norovirus |
4.1% |
| Hallucination, Visual |
4.1% |
| Hepatic Steatosis |
4.1% |
| Restlessness |
4.1% |
| Tic |
4.1% |
| Cholelithiasis |
2.7% |
| Circulatory Collapse |
2.7% |
| Fatigue |
2.7% |
| Hypotension |
2.7% |
| Jaundice |
2.7% |
|
| Concomitant |
| Hypertension |
17.4% |
| Product Used For Unknown Indication |
13.9% |
| Type 2 Diabetes Mellitus |
8.5% |
| Infection |
6.6% |
| Antibiotic Therapy |
5.8% |
| Depression |
5.4% |
| Psychotic Disorder |
5.4% |
| Diabetes Mellitus |
4.2% |
| Normal Pressure Hydrocephalus |
4.2% |
| Acute Myeloid Leukaemia |
3.9% |
| Pain |
3.1% |
| Schizophrenia |
3.1% |
| Tuberous Sclerosis |
3.1% |
| Drug Use For Unknown Indication |
2.7% |
| Restlessness |
2.7% |
| Convulsion |
2.3% |
| Antifungal Prophylaxis |
1.9% |
| Cardiac Failure |
1.9% |
| Fungal Infection |
1.9% |
| Oedema |
1.9% |
|
| Weight Decreased |
20.8% |
| Hyponatraemia |
7.5% |
| Somnolence |
7.5% |
| Syncope |
7.5% |
| Hypoglycaemia |
5.7% |
| Muscular Weakness |
5.7% |
| Blister |
3.8% |
| Drug Interaction |
3.8% |
| Retinal Pigment Epitheliopathy |
3.8% |
| Sepsis |
3.8% |
| Status Epilepticus |
3.8% |
| Torsade De Pointes |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Urinary Tract Infection |
3.8% |
| Vertigo Positional |
3.8% |
| Wrong Technique In Drug Usage Process |
3.8% |
| Antipsychotic Drug Level Above Therapeutic |
1.9% |
| Bedridden |
1.9% |
| Breast Cancer |
1.9% |
| Completed Suicide |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
74.6% |
| Dementia |
10.9% |
| Sleep Phase Rhythm Disturbance |
5.0% |
| Insomnia |
3.0% |
| Attention Deficit/hyperactivity Disorder |
2.0% |
| Circadian Rhythm Sleep Disorder |
2.0% |
| Hyperthyroidism |
1.0% |
| Depression |
0.5% |
| Multiple Sclerosis |
0.5% |
| Personality Disorder |
0.5% |
|
| Renal Failure |
34.5% |
| Drug Interaction |
13.8% |
| Sudden Death |
13.8% |
| Somnolence |
6.9% |
| Death |
3.4% |
| Hypotension |
3.4% |
| Restless Legs Syndrome |
3.4% |
| Restlessness |
3.4% |
| Syncope |
3.4% |
| Thrombocytopenia |
3.4% |
| Tremor |
3.4% |
| Ventricular Tachycardia |
3.4% |
| Vertigo |
3.4% |
|
